About Index Trending news
Lists
Pricing
Qu Biologics Inc.

Qu Biologics Inc.

Qu Biologics Inc.

Qu Biologics develops Site Specific Immunomodulators that aim to restore the body's innate immune system to treat cancer and immune-related diseases such as IBD

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Private equity
$4,000,000
Employees

Unknown size

Locations
HQ
Headquarters
$4,000,000 Private equity
PE Hub

Qu Biologics secures $4 mln more for immunotherapy research